Target is under pressure because products are more discretionary, says TD Cowan's Oliver Chen
Oliver Chen, TD Cowen senior retail analyst, joins 'Fast Money' to talk what to expect out of Target results tomorrow.
Vertex Pharmaceuticals Incorporated (VRTX) TD Cowen 45th Annual Health Care Conference (Transcript)
Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) TD Cowen 45th Annual Health Care Conference Transcript March 3, 2025 3:10 PM ET David Altshuler - Executive Vice President, Global Research and CSO ...
NetApp (NASDAQ:NTAP) Price Target Lowered to $130.00 at TD Cowen
NetApp (NASDAQ:NTAP – Free Report) had its price target cut by TD Cowen from $160.00 to $130.00 in a research report released ...
'Wouldn't be surprised' by a recession in second half of the year, says TD Cowen's Jeffrey Solomon
Mechanics Agree These Are the 2 Most Reliable Cars You Can Buy ...
Microsoft has dropped some AI data center leases, TD Cowen says
Microsoft Corp. has canceled some leases for US data center capacity, according to TD Cowen, raising broader concerns over ...
Bloom Energy (NYSE:BE) Price Target Raised to $20.00 at TD Cowen
Bloom Energy (NYSE:BE – Free Report) had its price target lifted by TD Cowen from $13.00 to $20.00 in a report released on Friday morning, MarketBeat.com reports. TD Cowen currently has a hold rating ...
TD Cowen Remains a Hold on Arcadium Lithium Plc (ALTM)
TD Cowen analyst David Deckelbaum maintained a Hold rating on Arcadium Lithium Plc (ALTM – Research Report) today and set a price target of ...
Microsoft kündigt Leasingverträge für KI-Rechenzentren: TD Cowen
Mit Blick auf den KI-Nachfrage-Ausblick lässt ein Bericht der Investmentbank TD Cowen aufhorchen: Microsoft hat demnach ...
Why analysts are divided over Trump’s crypto reserve announcement
Investment bank TD Cowen expressed skepticism about the plan, calling it "uncoordinated" and lacking clarity on funding.
TD Cowen Keeps Their Buy Rating on Spyre Therapeutics (SYRE)
In a report released yesterday, Tyler Van Buren from TD Cowen maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report). The ...